StockWatch
·

Profound Medical Corp. Q3 FY25 Results

PROFQ3 FY25 Results
MetricValue ($ M)vs Q2 FY25
Revenue5.06155.6%
Total Income5.06155.6%
Expenditure13.9711.5%
PBT-7.8649.7%
Net Profit-7.9849.2%
OPM—
NPM—
EPS0.2650.0%
View full financials

Informational and educational content only. Not investment advice.